UnitedHealth Group’s OptumRx and Walgreens entered a partnership to develop a new pharmacy solution that eases the consumer experience, decrease costs and enhances outcomes. 1. OptumRx manages more ...

OptumRx will pay $20 million to resolve claims the company violated the Controlled Substances Act by improperly filling certain opioid prescriptions, the Department of Justice recently announced. The ...

Health insurance companies are expected to hold to their promises in 2026 to “streamline, simplify and reduce” prior ...

OptumRx is paying $20 million to settle allegations the company broke federal law by mailing opioids alongside other medications without resolving red flags about whether they were for legitimate ...

OptumRx, Optum’s pharmacy benefit management company, has agreed to pay $20 million to settle allegations it improperly filled certain opioid prescriptions, violating the Controlled Substances Act.

OptumRx, a pharmacy benefit manager unit of UnitedHealth Group (NYSE:UNH), has reportedly agreed to a $20 million settlement following U.S. government claims that it improperly filled certain opioid ...

OptumRx overcharged Ohio’s Bureau of Workers’ Compensation on more than 1.3 million prescription claims, Ohio Attorney General Dave Yost claimed in a Feb. 8 court filing, The Columbus Dispatch ...

Rising prices set by pharmaceutical companies are causing pharmacies across the United States to pay more for many drugs, impacting their ability to maintain high-quality care for patients. Effective ...

Optum Rx is committed to making prescription drugs more affordable and the pharmacy experience simpler for consumers with chronic conditions, eliminating up to 25% of reauthorizations, which is equal ...

--(BUSINESS WIRE)--Optum Rx, a pharmacy services company, today announced additional actions to make insulin more affordable, moving several rapid-, short- and long-acting insulins to tier one, which ...

At the start of next year, pharmacy services company Optum Rx will place eight preferred insulin products on Tier One of standard commercial formularies, limiting out-of-pocket spend to $35 or less.